share_log
Breakings ·  Sep 19, 2024 04:09
Scisparc Takes Major Step Forward With Ind Application Submitted to the FDA for Phase Iib Clinical Trial for Tourette Syndrome Treatment
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment